Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Phase 1, Open-Label Study of MGD013, a Bispecific DART ® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jie Wang, MD, Adam S. Asch, MD, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, Andrew Weickhardt, MBBS(Hons) FRACP DMedSc, Monika Tomaszewska-Kiecana, Monika Dlugosz-Danecka, MD PhD, Halyna Pylypenko, MD, Shakeela Bahadur, MD, Susanna Ulahannan, MD MMed, Janine Koucheki, Jichao Sun, PhD, Hua Li, Francine Chen, MD, Xiaoyu Zhang, John Muth, MS, Patrick Kaminker, PhD, Paul Moore, PhD, Bradley James Sumrow, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139868

Published: 2020

Journal Articles

Tumor Antigen Vaccination of Donors to Augment Graft-Versus-Tumor Effects after Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide

Han-Hsuan Fu, PhD, Jie Wang, MD, Jie Fu, MS, Richard J Jones, MD, Hyam Levitsky, MD, Ephraim J. Fuchs, MD

Blood (2016) 128 (22): 499.

https://doi.org/10.1182/blood.V128.22.499.499

Published: 2016

Journal Articles

Utilization of Next Generation Sequencing Identifies Potentially Actionable Mutations with Prognostic Significance in Chronic Lymphocytic Leukemia

Jie Wang, MD, Jennifer J.D. Morrissette, PhD, E. Paul Wileyto, PhD, Stephen J. Schuster, MD, Alexandra Vandegrift, BA, Allison Rago, BSN, Colleen Dorsey, BSN, David Porter, MD, Daniel J. Landsburg, MD, Prioty Islam, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Alison Loren, MD MS, Scott Weber, BS, Edward A. Stadtmauer, MD, Anthony Mato, MD

Blood (2015) 126 (23): 2929.

https://doi.org/10.1182/blood.V126.23.2929.2929

Published: 2015

Journal Articles

Synergy between Nonmyeloablative Doses of Intravenous Busulfan and Post-Transplantation Cyclophosphamide for Induction of Tolerance to MHC-Compatible Stem Cell Allografts.

Xiaotao Zhou, MS, Jie Wang, MD, Moshe Y. Levy, MD, Heather Symons, MD, Ephraim J. Fuchs, MD

Blood (2005) 106 (11): 3040.

https://doi.org/10.1182/blood.V106.11.3040.3040

Published: 2005

Journal Articles

Effect of Intravenous Busulfan Versus Total Body Irradiation on Donor Chimerism and Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (AlloSCT) in Mice.

Jie Wang, MD, Xiaotao Zhou, MS, Heather Symons, MD, Moshe Y. Levy, MD, Ephraim J. Fuchs, MD

Blood (2005) 106 (11): 5254.

https://doi.org/10.1182/blood.V106.11.5254.5254

Published: 2005

Journal Articles

Therapeutic Anti-Tumor Immunity Mediated by Transiently Engrafting Allogeneic Lymphocytes: The “Allogeneic Effect” Revisited.

Heather J. Symons, MD, M. Yair Levy, MD, Jie Wang, MD, Xiaotao Zhou, MS, Ephraim J. Fuchs, MD

Blood (2005) 106 (11): 5255.

https://doi.org/10.1182/blood.V106.11.5255.5255

Published: 2005

Journal Articles

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8 + T Cells Responding to a Growing Tumor.

Jie Wang, MD, Maryam Aalamian, MD, Sanju Jalla, PhD, Leo Luznik, MD, Ephraim J. Fuchs, MD

Blood (2004) 104 (11): 3056.

https://doi.org/10.1182/blood.V104.11.3056.3056

Published: 2004

Journal Articles

Cyclophosphamide Plus Allogeneic CD4 + T Cell Infusion Induces Anti-Lymphoma Immunity Despite Lack of Graft-Versus-Host Disease (GVHD) or Sustained Engraftment.

Sanju Jalla, PhD, Jie Wang, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD

Blood (2004) 104 (11): 3063.

https://doi.org/10.1182/blood.V104.11.3063.3063

Published: 2004

Journal Articles

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Sanju Jalla, PhD, Erin McCadden, Jie Wang, MD, Ephraim J. Fuchs, MD, Katharine A. Whartenby, PhD

Blood (2004) 104 (11): 3175.

https://doi.org/10.1182/blood.V104.11.3175.3175

Published: 2004

NARROW

A Phase 1, Open-Label Study of MGD013, a Bispecific DART ® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Tumor Antigen Vaccination of Donors to Augment Graft-Versus-Tumor Effects after Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide

Utilization of Next Generation Sequencing Identifies Potentially Actionable Mutations with Prognostic Significance in Chronic Lymphocytic Leukemia

Synergy between Nonmyeloablative Doses of Intravenous Busulfan and Post-Transplantation Cyclophosphamide for Induction of Tolerance to MHC-Compatible Stem Cell Allografts.

Effect of Intravenous Busulfan Versus Total Body Irradiation on Donor Chimerism and Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (AlloSCT) in Mice.

Therapeutic Anti-Tumor Immunity Mediated by Transiently Engrafting Allogeneic Lymphocytes: The “Allogeneic Effect” Revisited.

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8 + T Cells Responding to a Growing Tumor.

Cyclophosphamide Plus Allogeneic CD4 + T Cell Infusion Induces Anti-Lymphoma Immunity Despite Lack of Graft-Versus-Host Disease (GVHD) or Sustained Engraftment.

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only